Nuzenio

Valirx

Valirx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 10:10:00 GMTValiRx subsidiary Cytolytix nears "significant" European patent win - London South East
Mon, 10 Aug 2026 07:52:14 GMTImmuPharma, ValiRx, Tertiary Minerals, Caledonia Mining, Sintana Energy - Small Cap Snapshot - Yahoo Finance
Mon, 10 Aug 2026 07:00:20 GMTValiRx strengthens Cytolytix cancer IP with European patent progress and new filing - Yahoo Finance UK
Mon, 10 Aug 2026 06:18:00 GMTValiRx set to land second European patent for Cytolytix cancer peptide - Yahoo Finance UK
Mon, 10 Aug 2026 06:01:17 GMTValiRx (VAL) Subsidiary Cytolytix Set to Secure Second European Patent for Core Anti-Cancer Peptide Technology - Kalkine Media
Sun, 09 Aug 2026 05:35:45 GMTValiRx PLC (GB00BLH13C52.SG) stock price, news, quote and history - Yahoo Finance Australia

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Valirx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.